NASDAQ · CYPHHealthcarePharmaceuticals

Cypherpunk Technologies financials

$3.23−2.42%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
Revenue$0.00
Gross profit$0.00
Gross margin—
Operating income-$41.1M
Net income$4.8M
Net margin—
Diluted EPS$0.07
EBITDA-$36.5M
Operating cash flow-$43.9M
Free cash flow-$43.9M
Diluted shares70.7M

Balance sheet

Period endDec 31
Cash & equivalents$14.0M
Short-term investments$0.00
Total debt$0.00
Total assets$163.2M
Total liabilities$9.7M
Shareholders' equity$153.5M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology